OptiCept Technologies

Background
The subscription period for exercise of the warrants of series TO5 took place during the period from and including 19 May 2023, up to and including 1 June 2023. The subscription price per share for exercising the warrants of series TO5 was set to SEK 5.64.

In total, 1,275,683 warrants of series TO5 were exercised for subscription of 1,275,683 shares, meaning that approximately 92.4 percent of all outstanding warrants of series TO5 were exercised for subscription of shares.

Shares that have been subscribed and paid for will be registered on the subscriber's securities depository as interim shares (IA) until registration of the issue has been completed with the Swedish Companies Registration Office, whereupon the interim shares automatically will be converted into shares in OptiCept.

Number of shares, share capital and dilution
Through the exercise of the warrants of series TO5, the number of shares in OptiCept increases by 1,275,683 shares, from 29,567,582 shares to a total of 30,843,265 shares. The share capital will increase by SEK 114,811.47, from SEK 2,661,082.38 to SEK 2,775,893.85.

For existing shareholders who did not exercise any warrants of series TO5, the dilution amounts to approximately 4.1 percent of the number of shares and votes in the Company.

Advisers
Pareto Securities AB acts as Sole Manager and Bookrunner, and Moll Wendén Advokatbyrå AB is legal adviser to the Company in connection with the exercise of warrants.